These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3740398)

  • 1. Cytotoxic-induced cardiomyopathy.
    Board J
    Anaesth Intensive Care; 1986 May; 14(2):210. PubMed ID: 3740398
    [No Abstract]   [Full Text] [Related]  

  • 2. [Doxorubicin-induced cardiomyopathy].
    Czarnecki A
    Pol Tyg Lek; 1983 Apr; 38(15):471-3. PubMed ID: 6356084
    [No Abstract]   [Full Text] [Related]  

  • 3. Case presentation of doxorubicin-induced cardiomyopathy: a short- and long-term side effect of pediatric cancer treatment.
    Dunn J
    J Pediatr Oncol Nurs; 1991 Apr; 8(2):84. PubMed ID: 1675089
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible cardiomyopathy due to doxorubicin.
    Murali A; Sujithkumar S; Srinivasan N; Kannan R
    Natl Med J India; 2010; 23(6):377-8. PubMed ID: 21563339
    [No Abstract]   [Full Text] [Related]  

  • 5. [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
    Rubio JA; Pulpón LA; Cavero MA; Oteo JF; Maicas C; Silva L; Serrano-Fiz S; Burgos R; Artaza M; Téllez G
    Rev Esp Cardiol; 1994 Nov; 47(11):777-9. PubMed ID: 7800910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic dilated cardiomyopathy.
    Legha SS
    N Engl J Med; 1995 May; 332(20):1385; author reply 1385-6. PubMed ID: 7536301
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy.
    Padberg S; Mick I; Frenzel C; Greil R; Hilberath J; Schaefer C
    Reprod Toxicol; 2017 Aug; 71():146-149. PubMed ID: 28552383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin.
    Katamadze NA; Lartsuliani KP; Kiknadze MP
    Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiological monitoring of patients treated with doxorubicin].
    Mahaux V; Demoulin JC; Closon MT; Jardon-Jeghers C; Vivario M; Kulbertus H
    Rev Med Liege; 1988 Jun; 43(12):449-55. PubMed ID: 3041526
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adriamycin cardiomyopathy].
    Nilles M; Wehr M; Köhler F
    Med Welt; 1984 Jan; 35(4):103-8. PubMed ID: 6700420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiotoxic effect of adriamycin].
    Shkhvatsabaia LV; Valvere VIu; Nekliudova VI
    Kardiologiia; 1988 Apr; 28(4):110-4. PubMed ID: 3292809
    [No Abstract]   [Full Text] [Related]  

  • 12. Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: a case report.
    Hadar A; Sheiner E; Press F; Katz A; Katz M
    J Reprod Med; 2004 May; 49(5):401-3. PubMed ID: 15214719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endothelin-1 and doxorubicin cardiotoxicity.
    Yamashita J; Ogawa M; Nomura K
    N Engl J Med; 1994 Dec; 331(22):1528-9. PubMed ID: 7969316
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiotoxicity of doxorubicin in children].
    Pilon JW; Naeff MS; Taminiau JA
    Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1339-43. PubMed ID: 6482993
    [No Abstract]   [Full Text] [Related]  

  • 15. Orthotopic heart transplantation: an efficient treatment in a young boy with doxorubicin-induced cardiomyopathy.
    Lüthy A; Furrer M; Waser M; Maggiorini M; Pluess HJ; Real F; Weiss B; Gallino A; Turina M
    J Heart Lung Transplant; 1992; 11(4 Pt 1):815-6. PubMed ID: 1323330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute cardiotoxicity following two intravenous doses of cyclophosphamide in an adolescent treated for rapidly progressive glomerulonephritis.
    Runowski D; Brzezińska M; Kowalczyk M; Grenda R
    Kardiol Pol; 2016; 74(9):1027. PubMed ID: 27654474
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicin.
    Sriskandan S; O'Brien ME; Smith IE; Collins P; Gore ME
    Postgrad Med J; 1994 Oct; 70(828):759-61. PubMed ID: 7831179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
    van den Berg MP; van Spaendonck-Zwarts KY; van Veldhuisen DJ; Gietema JA; Postma A; van Tintelen JP
    Eur J Heart Fail; 2010 Dec; 12(12):1297-9. PubMed ID: 20952769
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug overdose--a hidden hazard of obesity.
    Cox J; Penn N; Masood M; Hancock AK; Parker D
    J R Soc Med; 1987 Nov; 80(11):708-9. PubMed ID: 3694619
    [No Abstract]   [Full Text] [Related]  

  • 20. Usefulness of cardiac resynchronization therapy in the management of Doxorubicin-induced cardiomyopathy.
    Ajijola OA; Nandigam KV; Chabner BA; Orencole M; Dec GW; Ruskin JN; Singh JP
    Am J Cardiol; 2008 May; 101(9):1371-2. PubMed ID: 18435975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.